Search Within

Ross Levine

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (202)
  2. Meeting Abstract (194)
  3. Editorial (11)
  4. Review (9)
  5. Research Letter (5)
  6. Book Section (2)
  7. Guidelines (2)
  8. Book Whole (1)
Groups
  1. Adult Leukemia (426)
  2. Center for Hematologic Malignancies (426)
  3. Center for Molecular Imaging and Biotechnology (426)
  4. Department of Medicine (426)
  5. Executive Committee, Center for Hematologic Malignancies (426)
  6. GSK Faculty (426)

More Groups

People
  1. Martin Tallman (50)
  2. Raajit Rampal (43)
  3. Eytan Stein (40)
  4. Franck Rapaport (28)
  5. Alan Shih (26)
  6. Maria Kleppe (26)

More People

Years
  1. 2024 (9)
  2. 2023 (26)
  3. 2022 (22)
  4. 2021 (25)
  5. 2020 (30)
  6. 2019 (29)

More Years

Publications
  1. Blood (159)
  2. Leukemia (16)
  3. Haematologica (14)
  4. Blood Advances (13)
  5. Cancer Research (12)
  6. Swiss Medical Weekly (11)

More Publications

Publishers
  1. American Society of Hematology (174)
  2. Nature Publishing Group (46)
  3. American Association for Cancer Research (36)
  4. Cell Press (25)
  5. Elsevier Inc. (15)
  6. Ferrata Storti Foundation (14)

More Publishers

Results (426)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Loss of TET2 affects proliferation and drug sensitivity through altered dynamics of cell-state transitions
    Journal Article

    Morinishi, L.; Kochanowski, K.; Levine, R. L.; Wu, L. F.; Altschuler, S. J.
    Cell Systems (2020)

    Fulltext@MSK | Save
  • Leukemia secondary to myeloproliferative neoplasms
    Journal Article

    Dunbar, A. J.; Rampal, R. K.; Levine, R.
    Blood (2020)

    Fulltext@MSK | Save
  • Drug modulation by nuclear condensates: Concentration of antineoplastic agents into spatial compartments influences activity
    Editorial

    Viny, A. D.; Levine, R. L.
    Science (2020)

    Fulltext@MSK | Save
  • COVID-19 impact on early career investigators: A call for action
    Editorial

    Levine, R. L.; Rathmell, W. K.
    Nature Reviews Cancer (2020)

    Fulltext@MSK | Save
  • Inhibition of JAK2 suppresses myelopoiesis and atherosclerosis in Apoe (−/−) mice
    Journal Article

    Tang, Y.; Liu, W.; Wang, W.; Fidler, T.; Woods, B.; Levine, R. L.; Tall, A. R.; Wang, N.
    Cardiovascular Drugs and Therapy (2020)

    Fulltext@MSK | Save
  • Frequent RUNX1 and TP53 mutations in secondary acute myeloid leukemia with mixed phenotype
    Meeting Abstract

    Galera, P.; Baik, J.; Famulare, C.; Sigler, A.; Zhang, Y.; Arcila, M.; Dogan, A.; Tallman, M.; Levine, R.; Glass, J.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Prognostic impact of RAS-pathway mutations in patients with myelofibrosis
    Journal Article

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Datoguia, T. S.; Puga, R. D.; de Melo Alves Paiva, R.; Arcila, M. E.; Hamerschlak, N.; more...
    Leukemia (2020)

    Fulltext@MSK | Save
  • Mathematical modeling reveals alternative JAK inhibitor treatment in myeloproliferative neoplasms
    Research Letter

    Shank, K.; Dunbar, A.; Koppikar, P.; Kleppe, M.; Teruya-Feldstein, J.; Csete, I.; Bhagwat, N.; Keller, M.; Kilpivaara, O.; Michor, F.; more...
    Haematologica (2020)

    Fulltext@MSK | Save
  • Detection of marker-free precision genome editing and genetic variation through the capture of genomic signatures
    Journal Article

    Billon, P.; Nambiar, T. S.; Hayward, S. B.; Zafra, M. P.; Schatoff, E. M.; Oshima, K.; Dunbar, A.; Breinig, M.; Park, Y. C.; Ryu, H. S.; more...
    Cell Reports (2020)

    Fulltext@MSK | Save
  • Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia
    Journal Article

    Uckelmann, H. J.; Kim, S. M.; Wong, E. M.; Hatton, C.; Giovinazzo, H.; Gadrey, J. Y.; Krivtsov, A. V.; Rücker, F. G.; Döhner, K.; McGeehan, G. M.; more...
    Science (2020)

    Fulltext@MSK | Save